A detailed history of Regions Financial Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Regions Financial Corp holds 368,432 shares of LLY stock, worth $293 Million. This represents 2.36% of its overall portfolio holdings.

Number of Shares
368,432
Previous 366,194 0.61%
Holding current value
$293 Million
Previous $332 Million 1.55%
% of portfolio
2.36%
Previous 2.53%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $1.73 Million - $2.15 Million
2,238 Added 0.61%
368,432 $326 Million
Q2 2024

Jul 31, 2024

SELL
$724.87 - $909.04 $6.94 Million - $8.71 Million
-9,579 Reduced 2.55%
366,194 $332 Million
Q1 2024

Apr 23, 2024

SELL
$592.2 - $792.28 $5.75 Million - $7.7 Million
-9,717 Reduced 2.52%
375,773 $292 Million
Q4 2023

Feb 06, 2024

SELL
$525.19 - $619.13 $13.8 Million - $16.3 Million
-26,251 Reduced 6.38%
385,490 $225 Million
Q3 2023

Nov 01, 2023

SELL
$434.7 - $599.3 $1.73 Million - $2.39 Million
-3,988 Reduced 0.96%
411,741 $221 Million
Q2 2023

Aug 09, 2023

SELL
$350.74 - $468.98 $3.86 Million - $5.16 Million
-11,006 Reduced 2.58%
415,729 $195 Million
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $9.41 Million - $11 Million
-30,281 Reduced 6.63%
426,735 $147 Million
Q4 2022

Feb 03, 2023

SELL
$321.55 - $374.67 $3.25 Million - $3.78 Million
-10,100 Reduced 2.16%
457,016 $167 Million
Q3 2022

Nov 03, 2022

SELL
$296.48 - $337.87 $2.8 Million - $3.19 Million
-9,434 Reduced 1.98%
467,116 $151 Million
Q2 2022

Jul 25, 2022

SELL
$278.73 - $327.27 $11.7 Million - $13.8 Million
-42,087 Reduced 8.11%
476,550 $155 Million
Q1 2022

Apr 25, 2022

SELL
$234.69 - $291.66 $704,539 - $875,563
-3,002 Reduced 0.58%
518,637 $149 Million
Q4 2021

Jan 31, 2022

SELL
$224.85 - $279.04 $2.09 Million - $2.6 Million
-9,301 Reduced 1.75%
521,639 $144 Million
Q3 2021

Nov 04, 2021

SELL
$221.6 - $272.71 $9.23 Million - $11.4 Million
-41,659 Reduced 7.28%
530,940 $123 Million
Q2 2021

Jul 27, 2021

SELL
$180.55 - $233.54 $2.01 Million - $2.6 Million
-11,137 Reduced 1.91%
572,599 $131 Million
Q1 2021

Jun 02, 2021

SELL
$164.32 - $212.72 $1.97 Million - $2.55 Million
-12,001 Reduced 2.01%
583,736 $109 Million
Q4 2020

Feb 05, 2021

SELL
$130.46 - $172.63 $1.81 Million - $2.39 Million
-13,839 Reduced 2.27%
595,737 $101 Million
Q3 2020

Oct 15, 2020

SELL
$146.22 - $169.13 $4.25 Million - $4.92 Million
-29,071 Reduced 4.55%
609,576 $90.2 Million
Q2 2020

Jul 27, 2020

SELL
$136.42 - $164.18 $2.73 Million - $3.29 Million
-20,041 Reduced 3.04%
638,647 $105 Million
Q1 2020

Apr 29, 2020

SELL
$119.05 - $147.35 $3.9 Million - $4.82 Million
-32,726 Reduced 4.73%
658,688 $91.4 Million
Q4 2019

Feb 03, 2020

BUY
$106.92 - $132.43 $1.19 Million - $1.47 Million
11,108 Added 1.63%
691,414 $90.9 Million
Q3 2019

Oct 24, 2019

BUY
$106.79 - $116.16 $1.47 Million - $1.6 Million
13,811 Added 2.07%
680,306 $76.1 Million
Q2 2019

Jul 19, 2019

SELL
$110.79 - $129.32 $1.37 Million - $1.59 Million
-12,324 Reduced 1.82%
666,495 $73.8 Million
Q1 2019

Apr 19, 2019

SELL
$111.31 - $131.02 $8.35 Million - $9.83 Million
-74,999 Reduced 9.95%
678,819 $88.1 Million
Q4 2018

Jan 28, 2019

SELL
$105.9 - $118.64 $6.44 Million - $7.22 Million
-60,851 Reduced 7.47%
753,818 $87.2 Million
Q3 2018

Oct 22, 2018

SELL
$85.86 - $107.31 $2.68 Million - $3.34 Million
-31,166 Reduced 3.68%
814,669 $87.4 Million
Q2 2018

Jul 26, 2018

SELL
$75.7 - $86.88 $103,254 - $118,504
-1,364 Reduced 0.16%
845,835 $72.2 Million
Q1 2018

Apr 18, 2018

SELL
$74.21 - $87.6 $28.3 Million - $33.4 Million
-381,290 Reduced 31.04%
847,199 $65.5 Million
Q4 2017

Jan 18, 2018

BUY
$81.94 - $87.89 $2.01 Million - $2.15 Million
24,471 Added 2.03%
1,228,489 $104 Million
Q3 2017

Oct 23, 2017

BUY
$77.07 - $85.54 $92.8 Million - $103 Million
1,204,018
1,204,018 $103 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Regions Financial Corp Portfolio

Follow Regions Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Regions Financial Corp with notifications on news.